About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Pharma Companies in Race to Develop Ebola Drug

by Kathy Jones on August 12, 2014 at 11:11 PM
Font : A-A+

 Pharma Companies in Race to Develop Ebola Drug

Pharmaceutical companies are gearing up to become the first to come out with a treatment or vaccine for treating Ebola virus, even as the death toll continues to rise in West Africa.

While several experimental drugs exist, few have moved beyond the stage of animal tests and negotiations are under way to try and fast-track drugs for the haemorrhagic fever that kills up to 90 percent of people it infects.

Advertisement

These are some of the candidate drugs.

VACCINES:

A vaccine being developed by British pharma company GlaxoSmithKline (GSK) may enter clinical trials to test for safety and efficacy next month, World Health Organisation vaccines head Jean-Marie Okwo-Bele has told French radio.
Advertisement

He said results may be out by the end of the year, and "since this is an emergency, we can put emergency procedures in place... so that we can have a vaccine available by 2015."

The GSK vaccine, being developed with backing from the US National Institute for Allergy and Infectious Diseases (NIAID), is made of an engineered virus, or vector, containing two non-infectious Ebola genes.

The vector enters individual cells of a patient and stimulate them to create a protein against which the body will mount a defensive immune response.

NIAID director Anthony Fauci told AFP a vaccine "could be available for nursing staff by 2015".

The NIAID is also supporting the development of another vaccine which its maker, Johnson & Johnson subsidiary Crucell, said "has been shown to completely protect monkeys against the virus with a single dose".

A Phase I clinical trial with 32 volunteers started in 2006, and showed the drug to be safe at certain doses. A followup study is planned for late 2015 or early 2016.

American firm Profectus Biosciences has an animal virus-based vaccine in pre-clinical testing, and the Thomas Jefferson University in Pennsylvania is working on a candidate drug based on an established rabies vaccine.

TREATMENTS:

ZMapp, a cocktail of three antibodies manufactured by Mapp Biopharmaceutical, has been given to two American missionaries and more recently a Spanish priest, all infected with Ebola while working with patients in west Africa.

The Americans were said to have improved, but authorities say it is too early to tell whether this can be ascribed to the experimental drug, which has cured Ebola in mice and primates in tests.

US regulators last week loosened restrictions on another experimental drug, TKM-Ebola from Canada-based Tekmira, which may allow it to be tried on infected patients.

In tests on monkeys the drug, being developed under a $140-million (105-million-euro) contract with the US Department of Defense, provided 100 percent protection against an otherwise lethal dose of Ebola.

Other antiviral candidates include favipiravir, which started out as a flu treatment, and BCX4430 -- a broad-spectrum drug whose developers believe it may work against an array of viruses.

Herve Raoul, director of the high-security Inserm laboratory in Lyon, said finding an effective antiviral drug was of the highest priority.

A drug that can limit proliferation of the virus within a patient would allow their immune system to recover and make antibodies to fight the infection.

This would reduce the number of people falling severely ill, and create conditions conducive to improving sanitation, which is essential for halting the spread of a virus easily killed by soap and water.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Xenophobia Congo Fever Ebola Virus Disease 

Recommended Reading
Ebola Virus Disease
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have .....
Two Possible Ebola Cases in Benin Show Negative Test Results
Tests on two patients suspected for Ebola, in the west African country of Benin were found ......
Gambian National Airline Suspended by Nigeria Over Ebola Virus
The Gambian airline has been suspended by Nigeria from flying into the country, alleging ......
Ebola Outbreak may Have Spread to Rwanda
The Ebola virus may have spread to Rwanda after the country's health ministry confirmed that they .....
Congo Fever
Crimean-Congo Hemorrhagic fever (CCHF) is a viral disease that affects people who are bitten by infe...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Xenophobia
Xenophobia can be studied from two different perspectives. First as a medical condition ‘phobia’ sec...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use